síndrome pós-COVID-19 | sciencenewsnet.in

Breaking News

No ‘one size fits all’ treatment for Type 1 Diabetes, study finds

Chula Lecturer Wins Creative Excellence Award 2024 for “Decorative Toys for the Elderly”

Improved Spin and Density Correlation Simulations Give Researchers Clearer Insights on Neutron Stars

American Thyroid Association® Recognizes 2024 Van Meter Award Winner

Breakthrough in Hazardous Gas Detection: New Technology Enhances Miniaturization and Accuracy

Shells, teeth and bones of ‘weird and wonderful organisms’ provide historical environmental clues

Forestry Research Indexed in PubMed Central

Technology in Horticulture Successfully Indexed in Web of Science: Emerging Sources Citation Index (ESCI)

Delay and Pay: Tipping Point Costs Quadruple After Waiting

Amazon’s Return-to-Office Strategy: Expert Insights on Remote Work Challenges

27 Nov, 2024

Esperança para os pacientes com a síndrome pós-COVID

October 26, 2021 sarah JonasFeature

“As estimativas demonstram que 10 a 30 por cento das pessoas infectadas com a COVID-19 acabarão ficando com a COVID de longa duração”, afirma o Dr. Greg Vanichkachorn, diretor médico do Programa de Reabilitação de Atividades da COVID da Mayo Clinic.

Esperanza para pacientes con síndrome pos-COVID

October 26, 2021 sarah JonasFeature

“Las estimaciones indican que entre el 10 y el 30 por ciento de las personas que se infectan con COVID-19 terminarán con COVID de larga duración”, afirma el Dr. Greg Vanichkachorn, director médico del Programa de Rehabilitación de Actividades COVID de Mayo Clinic.